FibroGen, Inc. (FGEN)

FibroGen Stock Forecast

FGEN's stock price has decreased by -76.92% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for FibroGen stock has a target of 10, which predicts an increase of 3,242.25% from the current stock price of 0.30.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+3242.2%	+3242.2%	+3242.2%	+3242.2%

Analyst Ratings

According to 1 stock analyst, the rating for FibroGen is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	0	0	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	0	0	0
Sell	1	1	1	0	0	0
Strong Sell	1	1	1	0	0	0
Total	6	6	6	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+3,242.25%	Mar 18, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+3,242.25%	Feb 20, 2025
Jason Gerberry B of A Securities	B of A Securities	Hold → Sell Downgrades $4 → $2	Hold → Sell	Downgrades	$4 → $2	+568.45%	Aug 8, 2023
Paul Choi Goldman Sachs	Goldman Sachs	Strong Sell Maintains $16 → $2	Strong Sell	Maintains	$16 → $2	+568.45%	Jun 27, 2023
Danielle Brill Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jun 27, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

191.05M

Increased by 544.98%

from 29.62M

Revenue Next Year

209.10M

Increased by 9.45%

from 191.05M

EPS This Year

-0.72

from -0.48

EPS Next Year

-0.79

from -0.72

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	176.32M	235.31M	140.73M	46.80M	29.62M	191.05M	209.10M	241.43M
Revenue Growth	-31.28%	33.46%	-40.19%	-66.74%	-36.71%	544.98%	9.45%	15.46%
EPS	-2.11	-3.14	-3.14	-2.92	-0.48	-0.72	-0.79	-0.59
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	196.7M	215.3M	248.5M
Avg	191.1M	209.1M	241.4M
Low	183.6M	200.9M	232.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	564.0%	12.7%	18.9%
Avg	545.0%	9.4%	15.5%
Low	519.7%	5.2%	10.9%

EPS Forecast

EPS	2025	2026	2027	2028
High	-0.56	-0.72	-0.46
Avg	-0.72	-0.79	-0.59
Low	-0.86	-0.84	-0.71

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.